Efficacy of Liraglutide Therapy in Patients With IPAA
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
Patients with an ileal pouch-anal anastomosis(IPAA; pouch) due to refractory inflammatory
bowel disease and increased bowel frequency in the absence of significant pouch inflammation
will be randomized to liraglutide or placebo in a prospective cross over study.